Mavacamten, sold under the brand name Camzyos, is a medication used to treat obstructive hypertrophic cardiomyopathy. Mavacamten is a small-molecule allosteric and cardiac myosin inhibitor. From Wikipedia
The findings position myosin inhibition to challenge beta-blockers as first-line care pending FDA review of aficamten.
